Raymond H. Kim

10.0k total citations · 1 hit paper
157 papers, 5.0k citations indexed

About

Raymond H. Kim is a scholar working on Surgery, Genetics and Molecular Biology. According to data from OpenAlex, Raymond H. Kim has authored 157 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Surgery, 45 papers in Genetics and 32 papers in Molecular Biology. Recurrent topics in Raymond H. Kim's work include Total Knee Arthroplasty Outcomes (36 papers), BRCA gene mutations in cancer (27 papers) and Orthopaedic implants and arthroplasty (27 papers). Raymond H. Kim is often cited by papers focused on Total Knee Arthroplasty Outcomes (36 papers), BRCA gene mutations in cancer (27 papers) and Orthopaedic implants and arthroplasty (27 papers). Raymond H. Kim collaborates with scholars based in Canada, United States and United Kingdom. Raymond H. Kim's co-authors include Tak W. Mak, Douglas A. Dennis, David S. Park, Adrija Sharma, Hossein Aleyasin, Ruth S. Slack, Richard D. Komistek, Todd Miner, Steve Callaghan and Charlie C. Yang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Circulation.

In The Last Decade

Raymond H. Kim

135 papers receiving 4.9k citations

Hit Papers

Hypersensitivity of DJ-1-... 2005 2026 2012 2019 2005 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raymond H. Kim Canada 34 1.6k 1.4k 949 597 575 157 5.0k
Roberto Pola Italy 32 1.7k 1.1× 813 0.6× 342 0.4× 493 0.8× 309 0.5× 134 4.3k
Rodney D. McComb United States 37 1.3k 0.8× 492 0.3× 968 1.0× 433 0.7× 374 0.7× 112 4.1k
Peter S. Amenta United States 34 1.5k 0.9× 982 0.7× 434 0.5× 566 0.9× 177 0.3× 115 5.0k
Jin Ho Kim South Korea 31 848 0.5× 1.1k 0.8× 442 0.5× 210 0.4× 385 0.7× 224 4.5k
Takehiro Nakamura Japan 38 1.3k 0.8× 545 0.4× 1.7k 1.8× 274 0.5× 288 0.5× 158 4.8k
Marco Artico Italy 34 1.2k 0.7× 868 0.6× 781 0.8× 144 0.2× 329 0.6× 230 4.5k
Ryo Ogawa Japan 32 1.4k 0.9× 1.2k 0.9× 621 0.7× 151 0.3× 232 0.4× 271 4.4k
Susumu Ishida Japan 52 3.2k 2.0× 364 0.3× 582 0.6× 303 0.5× 332 0.6× 402 9.6k
Amar P. Dhillon United Kingdom 37 1.1k 0.7× 1.3k 0.9× 351 0.4× 389 0.7× 422 0.7× 80 5.1k
Zamaneh Kassiri Canada 48 2.4k 1.5× 1.3k 0.9× 505 0.5× 236 0.4× 184 0.3× 105 7.3k

Countries citing papers authored by Raymond H. Kim

Since Specialization
Citations

This map shows the geographic impact of Raymond H. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond H. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond H. Kim more than expected).

Fields of papers citing papers by Raymond H. Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond H. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond H. Kim. The network helps show where Raymond H. Kim may publish in the future.

Co-authorship network of co-authors of Raymond H. Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Raymond H. Kim. A scholar is included among the top collaborators of Raymond H. Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond H. Kim. Raymond H. Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sanabria‐Salas, María Carolina, et al.. (2025). Clinical integration of germline findings from a tumor testing precision medicine program. BMC Cancer. 25(1). 176–176.
2.
Stanton, Sasha E., Kristin G. Anderson, Tullia C. Bruno, et al.. (2025). SITC strategic vision: prevention, premalignant immunity, host and environmental factors. Journal for ImmunoTherapy of Cancer. 13(3). e010419–e010419.
3.
Mighton, Chloe, Katrina Hueniken, Vivek M. Philip, et al.. (2025). Pathogenic germline variants in small cell lung cancer: A systematic review and meta-analysis. Human Genetics and Genomics Advances. 6(3). 100445–100445.
4.
Scolari, Fernando Luís, Darshan H. Brahmbhatt, Sagi Abelson, et al.. (2024). Clonal Haematopoiesis is Associated with Major Adverse Cardiovascular Events in Patients with Hypertrophic Cardiomyopathy. European Journal of Heart Failure. 26(10). 2193–2202. 4 indexed citations
5.
Brent, Shannon E., Jacob McGee, Danielle Vicus, et al.. (2024). Rates of genetic consultation in high‐grade serous ovarian cancer patients in the era of PARP inhibitor therapy: A population‐based study. International Journal of Gynecology & Obstetrics. 166(1). 282–289. 1 indexed citations
6.
Hébert, Julien, Shabber Mannan, Eduardo Ng, et al.. (2024). Epilepsy in neurofibromatosis type 1: Prevalence, phenotype, and genotype in adults. Epilepsy Research. 202. 107336–107336. 2 indexed citations
7.
Manshaei, Roozbeh, et al.. (2024). A call for increased inclusivity and global representation in pharmacogenetic testing. npj Genomic Medicine. 9(1). 13–13. 3 indexed citations
8.
Wong, Derek, Ping Luo, Jeffrey P. Bruce, et al.. (2024). Cell-free DNA from germline TP53 mutation carriers reflect cancer-like fragmentation patterns. Nature Communications. 15(1). 7386–7386. 3 indexed citations
9.
Kim, Raymond H., et al.. (2023). Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis. Orphanet Journal of Rare Diseases. 18(1). 292–292. 29 indexed citations
10.
Li, Eric V., et al.. (2023). Developing a disease-specific annotation protocol for VHL gene curation using Hypothes.is. Database. 2023. 1 indexed citations
11.
Sanabria‐Salas, María Carolina, et al.. (2023). FLCN-Driven Functional Adrenal Cortical Carcinoma with High Mitotic Tumor Grade: Extending the Endocrine Manifestations of Birt-Hogg-Dubé Syndrome. Endocrine Pathology. 34(2). 257–264. 3 indexed citations
12.
Finch, Amy, Danny Vesprini, Raymond H. Kim, et al.. (2022). An appraisal of genetic testing for prostate cancer susceptibility. npj Precision Oncology. 6(1). 43–43. 5 indexed citations
13.
Oldfield, Leslie E., Elizabeth Chao, Gregory S. Downs, et al.. (2022). VHL mosaicism: the added value of multi-tissue analysis. npj Genomic Medicine. 7(1). 21–21. 11 indexed citations
14.
Cohn, Iris, Roozbeh Manshaei, Eriskay Liston, et al.. (2021). Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting. JAMA Network Open. 4(5). e2110446–e2110446. 24 indexed citations
15.
Miller, David T., Isidro Cortés‐Ciriano, Nischalan Pillay, et al.. (2020). Genomics of MPNST (GeM) Consortium: Rationale and Study Design for Multi-Omic Characterization of NF1-Associated and Sporadic MPNSTs. Genes. 11(4). 387–387. 13 indexed citations
16.
Jennings, Jason M., et al.. (2017). Magnitude of Deformity Correction May Influence Recovery of Quadriceps Strength After Total Knee Arthroplasty. The Journal of Arthroplasty. 32(9). 2730–2737. 5 indexed citations
17.
Jennings, Jason M., et al.. (2017). Direct Anterior Hip Replacement Does Not Pose Undue Radiation Exposure Risk to the Patient or Surgeon. Journal of Bone and Joint Surgery. 99(23). 2020–2025. 23 indexed citations
18.
McCuaig, Jeanna, Abdul Noor, Barry P. Rosen, et al.. (2016). Case Report: Use of Tumor and Germline Y Chromosomal Analysis to Guide Surgical Management in a 46, XX Female Presenting With Gonadoblastoma With Dysgerminoma. International Journal of Gynecological Pathology. 36(5). 466–470. 4 indexed citations
19.
Rousseaux, Maxime W.C., Paul C. Marcogliese, Dianbo Qu, et al.. (2012). Progressive dopaminergic cell loss with unilateral-to-bilateral progression in a genetic model of Parkinson disease. Proceedings of the National Academy of Sciences. 109(39). 15918–15923. 64 indexed citations
20.
Aleyasin, Hossein, Maxime W.C. Rousseaux, Paul C. Marcogliese, et al.. (2010). DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway. Proceedings of the National Academy of Sciences. 107(7). 3186–3191. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026